Opioids in Pain Control 1998
DOI: 10.1017/cbo9780511575068.007
|View full text |Cite
|
Sign up to set email alerts
|

Peripheral Opioid Analgesia: Mechanisms and Clinical Implications

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
21
0

Year Published

2001
2001
2012
2012

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 14 publications
(21 citation statements)
references
References 0 publications
0
21
0
Order By: Relevance
“…Many conventional opioid agonists have been shown to produce potent opioid receptor mediated analgesia when adminstered locally at small, systemically inactive doses into injured tissue of rodents and humans (75). Recent studies have confirmed these findings in nonhuman primates (31, 32).…”
Section: Analgesic Effects Of Exogenous Peripheral Opioid Agonistsmentioning
confidence: 92%
See 2 more Smart Citations
“…Many conventional opioid agonists have been shown to produce potent opioid receptor mediated analgesia when adminstered locally at small, systemically inactive doses into injured tissue of rodents and humans (75). Recent studies have confirmed these findings in nonhuman primates (31, 32).…”
Section: Analgesic Effects Of Exogenous Peripheral Opioid Agonistsmentioning
confidence: 92%
“…A large number of studies have shown that peripheral analgesic effects of exogenous opioids are enhanced under inflammatory conditions (61,75). One possible underlying mechanism is an upregulation, i. e., an increased number of receptors.…”
Section: Peripheral Opioid Receptors and Inflammationmentioning
confidence: 99%
See 1 more Smart Citation
“…One approach employed to circumventing these side effects has been to identify peripherally restricted KOP ligands (Arendt-Nielsen et al 2009;Camilleri 2008;DeHaven-Hudkins and Dolle 2004;Floyd et al 2009;Vanderah et al 2008). The rationale for this approach was that peripherally restricted KOP agonists would be devoid of dysphoria, and sedation seen with centrally acting agents but analgesic efficacy would be maintained given that activation of peripheral KOP receptors also produces antinociception (Stein 1993;Stein et al 1999).…”
Section: Development Of Kop Receptor Agonists As Analgesicsmentioning
confidence: 99%
“…These receptors are located on the primary afferents, in the spinal cord, and in the brain. The peripheral receptors are mainly important when inflammation is present (Stein, 1993;Stein et al, 1999;Labuz et al, 2007;Trescot et al, 2008). The receptor is the most abundant in the spinal cord and is the main modulator of the pain system, although ␦ and receptors seem to play a role during, for example, sensitization (Minami and Satoh, 1995).…”
mentioning
confidence: 99%